Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
S&P Global
SPGI
|
+$216M |
| 2 |
Charter Communications
CHTR
|
+$192M |
| 3 |
SLB Ltd
SLB
|
+$79.3M |
| 4 |
IBM
IBM
|
+$70.2M |
| 5 |
Newell Brands
NWL
|
+$67.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
GE Aerospace
GE
|
+$72.2M |
| 2 |
Microsoft
MSFT
|
+$66.1M |
| 3 |
Under Armour
UAA
|
+$63.2M |
| 4 |
ExxonMobil
XOM
|
+$51.6M |
| 5 |
WCN
Waste Connections
WCN
|
+$51.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 14.47% |
| 2 | Technology | 14.08% |
| 3 | Financials | 13.83% |
| 4 | Industrials | 10.22% |
| 5 | Consumer Discretionary | 9.32% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1901
Travere Therapeutics
TVTX
$5.78B
| $4.82M | ﹤0.01% |
270,805
+8,076
| +3% | +$131K |
|
1902
Green Plains
GPRE
$1.03B
| $4.81M | ﹤0.01% |
243,995
+1,609
| +0.7% | +$28.3K |
|
1903
Amphastar Pharmaceuticals
AMPH
$916M
| $4.81M | ﹤0.01% |
298,297
+17,017
| +6% | +$240K |
|
1904
Team
TISI
$77.7M
| $4.8M | ﹤0.01% |
19,351
-567
| -3% | -$159K |
|
|
NAV
1905
DELISTED
Navistar International
NAV
| $4.8M | ﹤0.01% |
410,870
+21,709
| +6% | +$269K |
|
|
SBY
1906
DELISTED
Silver Bay Realty Trust Corp.
SBY
| $4.8M | ﹤0.01% |
281,920
-15,791
| -5% | -$240K |
|
1907
McEwen Inc
MUX
$1.18B
| $4.79M | ﹤0.01% |
124,384
-1,147
| -0.9% | -$30.3K |
|
|
NEWR
1908
DELISTED
New Relic, Inc.
NEWR
| $4.79M | ﹤0.01% |
162,951
+23,123
| +17% | +$634K |
|
|
HTLF
1909
DELISTED
Heartland Financial USA, Inc.
HTLF
| $4.78M | ﹤0.01% |
135,352
+5,217
| +4% | +$174K |
|
|
KERX
1910
DELISTED
Keryx Biopharmaceuticals Inc
KERX
| $4.76M | ﹤0.01% |
719,245
+19,350
| +3% | +$108K |
|
|
SALE
1911
DELISTED
RetailMeNot, Inc. Series 1
SALE
| $4.75M | ﹤0.01% |
615,737
+22,562
| +4% | +$172K |
|
1912
Manitowoc
MTW
$675M
| $4.74M | ﹤0.01% |
217,648
+2,869
| +1% | +$62.4K |
|
1913
SiriusPoint
SPNT
$2.68B
| $4.74M | ﹤0.01% |
404,405
-12,467
| -3% | -$142K |
|
|
SAFE
1914
Safehold
SAFE
$1.15B
| $4.73M | ﹤0.01% |
101,333
-7,994
| -7% | -$376K |
|
1915
HealthStream
HSTM
$840M
| $4.72M | ﹤0.01% |
178,152
+2,863
| +2% | +$67.3K |
|
|
MNTA
1916
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
| $4.72M | ﹤0.01% |
437,137
+11,626
| +3% | +$120K |
|
1917
Veeco
VECO
$3.23B
| $4.7M | ﹤0.01% |
283,967
+4,102
| +1% | +$73K |
|
|
UBNK
1918
DELISTED
United Financial Bancorp, Inc.
UBNK
| $4.7M | ﹤0.01% |
361,989
+5,066
| +1% | +$65.7K |
|
|
FOLD
1919
DELISTED
Amicus Therapeutics
FOLD
| $4.68M | ﹤0.01% |
856,747
+15,290
| +2% | +$107K |
|
|
UNVR
1920
DELISTED
Univar Solutions Inc.
UNVR
| $4.65M | ﹤0.01% |
245,846
-2,377
| -1% | -$43.2K |
|
1921
Red Robin
RRGB
$152M
| $4.64M | ﹤0.01% |
97,879
+690
| +0.7% | +$39.9K |
|
1922
Gray Television
GTN
$552M
| $4.63M | ﹤0.01% |
427,008
-163,660
| -28% | -$1.93M |
|
|
BKS
1923
DELISTED
Barnes & Noble
BKS
| $4.62M | ﹤0.01% |
407,093
+26,659
| +7% | +$309K |
|
|
WPXP
1924
DELISTED
WPX Energy, Inc.
WPXP
| – | – |
0
| – | – |
|
|
CCC
1925
DELISTED
Calgon Carbon Corp
CCC
| $4.62M | ﹤0.01% |
351,079
-17,248
| -5% | -$255K |
|
Similar funds
Geode Capital Management's Q2 2016 Portfolio in Review
As of Q2 2016, Geode Capital Management held 4,187 positions worth $184B, up 97,477% from $188M the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Geode Capital Management's Q2 2016 filing shows 96 new, 2,386 increased, 984 reduced and 127 closed positions. Its largest new stake was S&P Global: 2,009,728 shares worth $215M. The largest sale was GE Aerospace, an estimated $72.2M.
By sector, the portfolio is most concentrated in Healthcare at 14% of assets, up from 14% a quarter earlier, followed by Technology and Financials.
- Geode Capital Management's largest Q2 2016 buy was S&P Global: 2,009,728 shares worth $215M.
- Geode Capital Management added most to Charter Communications in Q2 2016, an estimated $192M increase.
- Geode Capital Management's biggest Q2 2016 reduction was GE Aerospace, cutting an estimated $72.2M.
- Geode Capital Management fully exited Affymetrix Inc in Q2 2016, selling an estimated $7.53M.
- Geode Capital Management's ten largest holdings make up 15% of its $184B portfolio in Q2 2016.
- Geode Capital Management opened 96 new positions and closed 127 in Q2 2016.
- Geode Capital Management's portfolio value rose 97,477% quarter-over-quarter to $184B.
Based on Geode Capital Management's 13F filing for Q2 2016, filed 12 Aug 2016.